Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $27.1B
1-Year Return 23.24%
This Quarter Return
-20.46%
1 Year Return
+23.24%
3 Year Return
+64.59%
5 Year Return
+118.48%
10 Year Return
+210.79%
AUM
$9.63B
AUM Growth
-$2.48B
Cap. Flow
+$282M
Cap. Flow %
2.92%
Top 10 Hldgs %
42.19%
Holding
1,247
New
49
Increased
573
Reduced
264
Closed
32

Sector Composition

1 Real Estate 70.92%
2 Technology 5.34%
3 Financials 3.16%
4 Healthcare 3.13%
5 Industrials 2.63%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
XNCR icon
1026
Xencor
XNCR
$610M
$10K ﹤0.01%
320
AHT
1027
Ashford Hospitality Trust
AHT
$37.7M
$9K ﹤0.01%
12
ARVN icon
1028
Arvinas
ARVN
$575M
$9K ﹤0.01%
220
AUPH icon
1029
Aurinia Pharmaceuticals
AUPH
$1.63B
$9K ﹤0.01%
596
+64
+12% +$966
FATE icon
1030
Fate Therapeutics
FATE
$116M
$9K ﹤0.01%
410
IRWD icon
1031
Ironwood Pharmaceuticals
IRWD
$188M
$9K ﹤0.01%
885
TPTX
1032
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$9K ﹤0.01%
202
EPZM
1033
DELISTED
Epizyme, Inc
EPZM
$9K ﹤0.01%
571
TCF
1034
DELISTED
TCF Financial Corporation Common Stock
TCF
$9K ﹤0.01%
+400
New +$9K
AMRN
1035
Amarin Corp
AMRN
$317M
$8K ﹤0.01%
100
CLPR
1036
Clipper Realty
CLPR
$71.2M
$8K ﹤0.01%
1,500
GLPG icon
1037
Galapagos
GLPG
$2.2B
$8K ﹤0.01%
40
-6
-13% -$1.2K
INSM icon
1038
Insmed
INSM
$30.7B
$8K ﹤0.01%
504
PCRX icon
1039
Pacira BioSciences
PCRX
$1.19B
$8K ﹤0.01%
236
SAGE
1040
DELISTED
Sage Therapeutics
SAGE
$8K ﹤0.01%
292
-3,431
-92% -$94K
TBPH icon
1041
Theravance Biopharma
TBPH
$703M
$8K ﹤0.01%
348
+28
+9% +$644
AKCA
1042
DELISTED
Akcea Therapeutics, Inc. Common Stock
AKCA
$8K ﹤0.01%
530
ALK icon
1043
Alaska Air
ALK
$7.28B
$7K ﹤0.01%
248
BHR
1044
Braemar Hotels & Resorts
BHR
$203M
$7K ﹤0.01%
4,273
INVA icon
1045
Innoviva
INVA
$1.29B
$7K ﹤0.01%
572
KPTI icon
1046
Karyopharm Therapeutics
KPTI
$57.2M
$7K ﹤0.01%
24
LGND icon
1047
Ligand Pharmaceuticals
LGND
$3.25B
$7K ﹤0.01%
147
-12
-8% -$571
RGNX icon
1048
Regenxbio
RGNX
$490M
$7K ﹤0.01%
208
VCYT icon
1049
Veracyte
VCYT
$2.55B
$7K ﹤0.01%
276
DRNA
1050
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$7K ﹤0.01%
386